TMCnet News
Converge Partners with Lucira Health to Provide First Single-Use, PCR Quality Over the Counter COVID-19 At-Home TestTORONTO and GATINEAU, QC, April 29, 2021 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) a software-enabled IT & Cloud Solutions provider, in partnership with Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over-the-counter sale of the LUCIRA™ CHECK IT test kit that delivers PCR quality molecular accuracy in 30 minutes or less at home. This product is the first and only FDA EUA authorized, single-use, over the counter molecular diagnostic test for COVID-19 that can be self-administered by individuals at home. The Lucira test is also FDA EUA authorized for use in a physician's office. It is authorized and available for individuals with or without symptoms and can be ordered from lucirahealth.com for $55. Converge partnered with Lucira to support people who would like to quickly receive confirmation of their test results for work and other needs by developing a secure, text-based way for people with smartphones to receive a free LUCI PASS™ and verified test to their phone. "Converge s honored to have been part of the development of the first FDA EUA authorized, self-administered COVID-19 home test," stated Shaun Maine, CEO of Converge. "The opportunity to use Converge's solution capabilities in partnership with Lucira's health testing platform is an exciting use of technology to help others monitor their health in a positive and empowering way. The ability to order and test for COVID-19 at home is a huge step forward in increased access to health options that fit every lifestyle. Additionally, the verification of a negative COVID test via the LUCI PASS™ brings us one step closer to in-person interactions, creating shared trust to safely travel, work, or attend events with others." "Seeing the LUCI PASS™ in action at a recent Philadelphia 76ers game was really exciting. It shows how something as simple as a digital Lucira test result verification can play a role in helping the economy reopen. Users simply take the Lucira at home test and use the LUCI portal to obtain their LUCI PASS™ with their verified negative COVID test result," said Dr. Jonathan Gough, Project Lead for Lucira. "We designed LUCI to be intuitive and easy to use. It doesn't even require an app. It's something anyone with a smartphone can use and it opens up a world of possibility for users to easily show their negative COVID status to attend events like NBA games, work, and travel." About Converge About Lucira Health, Inc. View original content to download multimedia:http://www.prnewswire.com/news-releases/converge-partners-with-lucira-health-to-provide-first-single-use-pcr-quality-over-the-counter-covid-19-at-home-test-301280169.html SOURCE Converge Technology Solutions Corp. |